WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
China Amends Anti-Monopoly Law
Alerts
August 18, 2022

This month, important amendments to the Chinese Anti-Monopoly Law (AML) came into force. Implementing regulations are now being finalized which will provide further detail on each set of changes.1 The Chinese antitrust regulator, the State Administration for Market Regulation (SAMR), has concurrently proposed higher revenue thresholds for merger filings, with the final text expected by the end of this year.

After the new revenue thresholds are implemented, SAMR will have to be notified of a transaction if either: 1) the Chinese turnover of each of at least two of the parties to the concentration is over RMB 800 million (US $117.9 million) (formerly RMB 400 million (US $58.9 million)) and 2) there is a combined worldwide turnover of all the parties to the concentration of over RMB 12 billion (US $1.8 billion) (formerly RMB 10 billion (US $1.5 billion)); or the combined Chinese turnover of all the parties to the concentration is over RMB 4 billion (US $589.4 million) (formerly RMB 2 billion (US $294.7 million)).

Additionally, a new hybrid threshold is to be added to tackle so-called "killer acquisitions," where an incumbent firm acquires a competitor at an early stage of its development to "kill off" its competitive innovative product or technology. Under this threshold, SAMR will need to be notified of a merger if: 1) the Chinese turnover of one party to the concentration is over RMB 100 billion (US $14.7 billion), and 2) the other party to the concentration has a market value over RMB 800 million (US $117.9 million) and its Chinese turnover is over one-third of its total turnover. Furthermore, SAMR will now be able to review transactions below these thresholds if it believes there is evidence that they are anti-competitive. If a transaction has not already closed, once SAMR calls it in the parties cannot close until they receive clearance from SAMR. If a transaction has already closed, the parties must cease implementation or take other measures necessary to restore competition.

In short, raising the thresholds will make more deals non-reportable in China, will reduce the filing burdens for merging parties generally, and is a welcome development for parties engaged in M&A activity in the country. SAMR's greater ability to intervene in transactions may create more uncertainty for dealmakers, particularly in sectors in which the regulator takes a keen interest. Nevertheless, the requirement for a clear nexus to China when this power is to be used should help to define the boundaries of SAMR's jurisdictional reach, and it should also be welcomed. Merging parties will need to carefully analyze whether their transaction has any Chinese nexus, and if so, prepare for a potential call-in by SAMR.

For more information, please contact Beau Buffier, Mike Casey, Jamillia Ferris, Michelle Yost Hale, or another member of the global antitrust and competition practice at Wilson Sonsini Goodrich & Rosati.

Beau Buffier, Liam Boylan, and Carolina Ramalho dos Santos contributed to the preparation of this Wilson Sonsini alert.


[1] See the State Administration for Market Regulation’s drafts “Notification Thresholds Rules” and “Merger Review Rules,” which correspond to the revision of the two existing merger control implementation regulations, respectively: The Rules of the State Council on the Notification Thresholds for Concentration of Undertakings, and The Rules on the Review of Concentrations of Undertakings.

Contributors

  • Beau Buffier
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.